As vimentin is highly expressed in stromal fibroblasts it is not likely to be useful as a marker for differentiating pancreatic cancers from pancreatitis, but interestingly autoantibodies to this protein have been recently reported (Hong et al, 2006). This evidence concerns the gene VIM and familial pancreatic carcinoma.